iRhythm Technologies, Inc.(IRTC)

Sector:

Healthcare

Description:

iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

Current Price

$105.66

RSI

12.92

Market Capitalization:

4.1B

Beta:

1.099

Volume:

712,109

Analyst Target Price:

$ 157

Economiic Fair Price:


November 01, 2022
November 04, 2022
Q3
N/A
N/A
N/A
N/A
N/A
71.2M
129.3M
-3.456
-31.40 %
11.01
-0.326

18.81 %
-86.63 %
-418.08 %
21.59 %
9.74 %
-1178.53 %

$ 322.8M
21.74 %
$ 265.2M
23.59 %
$ 214.6M
45.66 %
$ 147.3M
49.52 %
$ 98.5M
53.75 %
$ 64.1M

$ -65.8M
-141.01 %
$ -27.3M
35.47 %
$ -42.3M
-23.57 %
$ -34.2M
-85.39 %
$ -18.5M
4.85 %
$ -19.4M

$ -101M
-131.63 %
$ -43.6M
20.00 %
$ -54.5M
-12.99 %
$ -48.2M
-63.96 %
$ -29.4M
-40.75 %
$ -20.9M

News

Press Releases

Notable Dates